MetaCap

TPG Mortgage Investment (MITT) vs Zimmer Biomet (ZBH)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.

Summary

Zimmer Biomet (ZBH) has outperformed TPG Mortgage Investment (MITT) over the past year, losing 9.6% versus a loss of 20.9%. Over five years, ZBH leads with a -37.5% price change compared with -53.8% for MITT. Zimmer Biomet is the larger company by market cap ($16.95 billion vs $181.0 million), about 93.7 times the size.

On valuation, TPG Mortgage Investment trades at a lower forward P/E (4.7x vs 9.8x for Zimmer Biomet). TPG Mortgage Investment offers the higher dividend yield (16.17% vs 1.08%).

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

MITT-20.86%ZBH-9.64%
+31%+3%-25%
Oct 8, 20251 yearOct 8, 2026
MITT-50.31%ZBH-37.57%
+18%-27%-71%
Oct 4, 20215 yearsOct 5, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

MITT versus ZBH key metrics
MetricMITTZBH
Share price$5.69$88.88
Market cap$180.96M$16.95B
1-day change+1.79%+0.44%
YTD return-33.22%-1.16%
1-year return-20.86%-9.64%
5-year return-53.81%-37.45%
P/E ratio (TTM)7.6921.57
Forward P/E4.699.80
EPS (TTM)$0.74$4.12
Dividend yield16.17%1.08%
Annual dividend$0.92$0.96
Revenue (latest FY)—$8.23B
Revenue growth (YoY)—+7.20%
Net income (latest FY)—$705.10M
Gross margin—69.71%
Operating margin—13.34%
Net margin—8.57%
52-week high$9.27$106.88
52-week low$5.50$79.12
Distance from 52-week high-38.62%-16.84%
Analyst consensusnonebuy
Avg. price target upside+58.17%+20.65%
Average volume313.91K2.17M
Shares outstanding31.80M190.74M
Employees—17,000
SectorReal EstateHealth Care
IndustryReal Estate Investment TrustsIndustrial Specialties

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • Zimmer Biomet is about 93.7 times larger than TPG Mortgage Investment by market value ($16.95B vs $180.96M).
  • ZBH has outperformed MITT by 11.2 percentage points over the past year.
  • Zimmer Biomet trades at a higher earnings multiple (21.6x vs 7.7x trailing P/E).
  • TPG Mortgage Investment offers a meaningfully higher dividend yield (16.17% vs 1.08%).
  • The two companies sit in different sectors: TPG Mortgage Investment in Real Estate and Zimmer Biomet in Health Care.

About TPG Mortgage Investment

MITT stock →

TPG Mortgage Investment Trust, Inc. operates as a residential mortgage real estate investment trust in the United States.

Real Estate · Real Estate Investment Trusts

About Zimmer Biomet

ZBH stock →

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T.

Health Care · Industrial Specialties · 17,000 employees

MITT vs ZBH FAQ

Which is bigger, TPG Mortgage Investment or Zimmer Biomet?

Zimmer Biomet (ZBH) is larger, with a market capitalization of $16.95B compared with $180.96M for TPG Mortgage Investment (MITT).

Which stock has performed better over the past year, MITT or ZBH?

ZBH returned -9.64% over the past 12 months, compared with -20.86% for MITT (price return, excluding dividends). Past performance does not predict future results.

Which has the lower P/E ratio, MITT or ZBH?

MITT has the lower trailing P/E at 7.7, versus 21.6 for ZBH. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.

Which pays a higher dividend, TPG Mortgage Investment or Zimmer Biomet?

TPG Mortgage Investment has the higher yield at 16.17%, compared with 1.08% for Zimmer Biomet.

Are TPG Mortgage Investment and Zimmer Biomet in the same industry?

No. TPG Mortgage Investment is in the Real Estate sector, while Zimmer Biomet is in Health Care.

More comparisons